Literature DB >> 26767830

Development of sandwich ELISAs that can distinguish different types of coxsackievirus A16 viral particles.

Xiangzhong Ye1, Lisheng Yang2, Jizong Jia1, Jinle Han1, Shuxuan Li2, Yajing Liu2, Longfa Xu2, Huan Zhao2, Yixin Chen2, Yimin Li1, Tong Cheng3, Ningshao Xia2.   

Abstract

Coxsackievirus A16 (CA16) is one of the major causative agents of hand, foot, and mouth disease (HFMD). No CA16 vaccine candidates have progressed to clinical trials so far. Immunogenicity studies indicated that different CA16 particles have much influence on the efficacy of a candidate vaccine. However, there are still no relevant reports on the methods of detecting different CA16 particles. In this study, we screened several monoclonal antibodies (mAbs) specific for different CA16 particles, and several sandwich enzyme-linked immunoassays (ELISAs) were developed to measure the different types of CA16 viral particles. The mAbs that could only bind denatured or empty capsids could not neutralize CA16. In contrast, the mAbs that could bind mature full particles or all types of particles showed obvious neutralizing activity. The thermal stability of different CA16 particles was evaluated using these sandwich ELISAs. The mature full particles were found to be more thermolabile than the other types of particles and could be stabilized by high concentrations of cations. These methods can be used to assist in the potency control of CA16 vaccines and will promote the development of a CA16 vaccine.

Entities:  

Keywords:  Antibody; Coxsackievirus A16; Enzyme-linked immunoassay; Hand, foot, and mouth disease; Particle; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 26767830     DOI: 10.1007/s00253-016-7296-z

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  3 in total

1.  A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge.

Authors:  Ruixiao Du; Qunying Mao; Yalin Hu; Shuhui Lang; Shiyang Sun; Kelei Li; Fan Gao; Lianlian Bian; Ce Yang; Bopei Cui; Longfa Xu; Tong Cheng; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

2.  Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16.

Authors:  Maozhou He; Longfa Xu; Qingbing Zheng; Rui Zhu; Zhichao Yin; Zhenghui Zha; Yu Lin; Lisheng Yang; Yang Huang; Xiangzhong Ye; Shuxuan Li; Wangheng Hou; Yangtao Wu; Jinle Han; Dongxiao Liu; Zekai Li; Zhenqin Chen; Hai Yu; Yuqiong Que; Yingbin Wang; Xiaodong Yan; Jun Zhang; Ying Gu; Z Hong Zhou; Tong Cheng; Shaowei Li; Ningshao Xia
Journal:  Cell Host Microbe       Date:  2020-02-05       Impact factor: 21.023

3.  A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccine.

Authors:  Bopei Cui; Fang Cai; Fan Gao; Lianlian Bian; Ruixia Wu; Ruixiao Du; Xing Wu; Pei Liu; Lifang Song; Lisha Cui; Yadi Yuan; Siyuan Liu; Xiangzhong Ye; Tong Cheng; Qunying Mao; Qiang Gao; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2020-08-04       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.